Français
ItalianoBond AbbVie 4.65% ( US00287YEM75 ) in USD
| Issuer | AbbVie | ||||||||||
| Market price |  98.2 % ▲ |
||||||||||
| Country |  United States
|
||||||||||
| ISIN code |
 US00287YEM75 ( in USD )
|
||||||||||
| Interest rate | 4.65% per year ( payment 2 times a year) | ||||||||||
| Maturity | 03/15/2030 | ||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 1 250 000 000 USD | ||||||||||
| Cusip | 00287YEM7 | ||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 03/15/2027 ( In 127 days ) | ||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEM75, pays a coupon of 4.65% per year. The coupons are paid 2 times per year and the Bond maturity is 03/15/2030 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEM75, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEM75, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||
| |||||||||||